Evidence map›Paper›PMID 35991237›Full record

ArticlePakistan journal of medical sciences

Acute and subacute toxicity studies of a poly herbal formulation used for diabetes.

Aymen Owais Ghauri, Ejaz Mohiuddin, Tayyeba Rehman, Hk Sheraz Muhammad Siddiqui

Open access · goldAbstract read
In one paragraph

Article in Pakistan journal of medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Antidiabetic Effect ofScientifica · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Aymen Owais GhauriAymen Owais Ghauri, PhD Eastern Medicine (fellow) Department of Eastern Medicine, Jinnah University for Women, Karachi, 74600, Pakistan. Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan.
Ejaz MohiuddinDr. Ejaz Mohiuddin, MBBS PhD Eastern Medicine Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan.
Tayyeba RehmanTayyeba Rehman, M.Phil. Phytomedicine University College of Conventional Medicine, Faculty of Medicine and Allied Health Sciences, The Islamia University of Bahawalpur, Bahawalpur (63100), Pakistan.
Hk Sheraz Muhammad SiddiquiDr. Hk. Sheraz Muhammad Siddiqui, PhD Eastern Medicine Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan.
Hamdard University · PKIslamia University of Bahawalpur · PKJinnah University for Women · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: PHF-dia (Poly Herbal Formulation Diabetes) is a polyhedral formulation possessing antihyperglycemic and antihyperlipdimic effects. This study aims to assess acute and sub-acute toxicity of PHF-dia in rats. Methods: This is an experimental study conducted in two different phases. Acute toxicity was conducted for 14 days and sub-acute toxicity was conducted for 28 days. Both studies were conducted in animal house of Jinnah University for Women, Karachi, Pakistan. Acute toxicity was evaluated in vivo with single time oral administration of 400 mg/kg and 2000 mg/kg doses for two weeks. Sub-acute toxicity was investigated with the application of repeated doses of 150 mg/kg/day, 250 mg/kg/day and 500 mg/kg/day for 28 days. Results: Acute toxicity study results showed no toxic symptoms, behavioral changes or death in rats up to 2000 mg/kg. Therefore, LD Conclusion: This indicates safe nature of PHF-dia for the further clinical trials. However, mechanism of action of PHF-dia is not fully understood.

Indexed as

DiabetesPHF-diaPoly herbal formulationToxicity

Identifiers

PMID35991237
PMCPMC9378416
OpenAlexW4293059510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.